Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

HealthLynked (HLYK) Common Equity (2016 - 2025)

HealthLynked (HLYK) has disclosed Common Equity for 10 consecutive years, with -$5.8 million as the latest value for Q4 2025.

  • Quarterly Common Equity fell 84.13% to -$5.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$5.8 million through Dec 2025, down 84.13% year-over-year, with the annual reading at -$5.8 million for FY2025, 84.13% down from the prior year.
  • Common Equity for Q4 2025 was -$5.8 million at HealthLynked, down from -$5.4 million in the prior quarter.
  • The five-year high for Common Equity was $8.8 million in Q3 2021, with the low at -$5.8 million in Q4 2025.
  • Average Common Equity over 5 years is $1.2 million, with a median of $1.2 million recorded in 2023.
  • The sharpest move saw Common Equity surged 2392.9% in 2021, then crashed 1967.95% in 2025.
  • Over 5 years, Common Equity stood at $7.2 million in 2021, then plummeted by 95.63% to $314450.0 in 2022, then soared by 155.92% to $804730.0 in 2023, then tumbled by 488.85% to -$3.1 million in 2024, then plummeted by 84.13% to -$5.8 million in 2025.
  • According to Business Quant data, Common Equity over the past three periods came in at -$5.8 million, -$5.4 million, and -$4.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.